First Time Loading...

Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 119.49 USD 0.04%
Updated: Apr 19, 2024
Section:
 

Relative Value

The Relative Value of one ZBH stock under the Base Case scenario is 185.3 USD. Compared to the current market price of 119.49 USD, Zimmer Biomet Holdings Inc is Undervalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ZBH Relative Value
Base Case
185.3 USD
Undervaluation 36%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.3
P/S
P/S
Price to Sales
3.3
vs History
65
vs Industry
36
Median 3Y
3.7
Median 5Y
3.6
Industry
2.4
Forward
3.1
More Details
24
P/E
P/E
Price to Earnings
24
vs History
71
vs Industry
23
Median 3Y
59.1
Median 5Y
46.3
Industry
23.4
Forward
14.8
More Details
15.6
P/OCF
P/OCF
Price to OCF
15.6
vs History
85
vs Industry
26
Median 3Y
18.3
Median 5Y
17.8
Industry
15.5
More Details
32.6
P/FCFE
P/FCFE
Price to FCFE
32.6
vs History
49
vs Industry
18
Median 3Y
33.2
Median 5Y
32.5
Industry
23.5
More Details
2
P/B
P/B
Price to Book Value
2
vs History
74
vs Industry
43
Median 3Y
2.1
Median 5Y
2.1
Industry
2.3
More Details
3.9
EV/S
EV/S
Enterprise Value to Sales
3.9
vs History
79
vs Industry
29
Median 3Y
4.4
Median 5Y
4.3
Industry
2.5
Forward
3.7
More Details
5.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.5
vs History
82
vs Industry
41
Median 3Y
6.2
Median 5Y
6
Industry
5.3
More Details
12
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12
vs History
95
vs Industry
28
Median 3Y
14.6
Median 5Y
14.2
Industry
12.6
Forward
10.3
More Details
19.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.8
vs History
95
vs Industry
24
Median 3Y
25.5
Median 5Y
25.5
Industry
17.1
Forward
13
More Details
18.4
EV/OCF
EV/OCF
Enterprise Value to OCF
18.4
vs History
92
vs Industry
24
Median 3Y
21.7
Median 5Y
21.6
Industry
15
More Details
32.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
32.6
vs History
61
vs Industry
16
Median 3Y
33.1
Median 5Y
36
Industry
19.6
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
58
vs Industry
49
Median 3Y
1.5
Median 5Y
1.4
Industry
2
More Details

Multiples Across Competitors

ZBH Competitors Multiples
Zimmer Biomet Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Zimmer Biomet Holdings Inc
NYSE:ZBH
24.7B USD 3.3 24 12 19.8
US
Abbott Laboratories
NYSE:ABT
186.4B USD 4.6 32.4 19.3 28.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
130.6B USD 18.2 72.2 56 70.3
US
Stryker Corp
NYSE:SYK
124.3B USD 6 39.2 24.5 30.3
IE
Medtronic PLC
NYSE:MDT
105.8B USD 3.3 25.1 13.5 19
US
Boston Scientific Corp
NYSE:BSX
99.5B USD 6.9 62.9 29.6 44.2
US
Becton Dickinson and Co
NYSE:BDX
67.8B USD 3.5 55.5 18.6 39.3
DE
Siemens Healthineers AG
XETRA:SHL
56.8B EUR 2.6 37.4 18 30.4
US
Edwards Lifesciences Corp
NYSE:EW
51.9B USD 8.6 37 26.8 29
US
Dexcom Inc
NASDAQ:DXCM
51.7B USD 14.3 95.4 64.3 83.7
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
328.2B CNY 9.5 28.9 25 25

See Also

Summary
ZBH intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZBH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZBH stock valuation using valuation multiples.
Wall Street Estimates
ZBH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZBH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 129,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.